“A Reduced Fixed Dose of Tocilizumab 200 Mg Compared to 400 Mg in Patients With Severe COVID-19 Disease”. One Health & Risk Management 4, no. 4 (September 29, 2023): 19–26. Accessed July 11, 2026. https://ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/374.